Skip to Main content

Keywords

Number of documents

86

Magali Morelle


Journal articles64 documents

  • Lidia Delrieu, Marina Touillaud, Olivia Pérol, Agnès Martin, Magali Morelle, et al.. Impact of Physical Activity on Oxidative Stress Markers in Patients with Metastatic Breast Cancer. Oxidative Medicine and Cellular Longevity, Hindawi, 2021, 2021, pp.1-9. ⟨10.1155/2021/6694594⟩. ⟨halshs-03432612⟩
  • Lidia Delrieu, Agnès Martin, Marina Touillaud, Olivia Pérol, Magali Morelle, et al.. Sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer: results from the ABLE feasibility trial. Breast Cancer Research and Treatment, Springer Verlag, 2021, 188 (3), pp.601-613. ⟨10.1007/s10549-021-06238-z⟩. ⟨halshs-03432614⟩
  • Laurie Besson, Benoite Mery, Magali Morelle, Yamila Rocca, Pierre Etienne Heudel, et al.. Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and Number. Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2021, 206 (10), pp.2265-2270. ⟨10.4049/jimmunol.2001215⟩. ⟨hal-03432391⟩
  • Olivia Febvey-Combes, Elodie Jobard, Adrien Rossary, Vincent Pialoux, Aude-Marie Foucaut, et al.. Effects of an Exercise and Nutritional Intervention on Circulating Biomarkers and Metabolomic Profiling During Adjuvant Treatment for Localized Breast Cancer: Results From the PASAPAS Feasibility Randomized Controlled Trial. Integrative Cancer Therapies, SAGE Publications, 2021, 20, pp.153473542097766. ⟨10.1177/1534735420977666⟩. ⟨hal-03445390⟩
  • Valentin Calugaru, Pascal Pommier, Paul Giraud, Philippe Giraud, Eliot Nicolas, et al.. Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers. Cancers, MDPI, 2020, 13 (1), pp.57. ⟨10.3390/cancers13010057⟩. ⟨hal-03146371⟩
  • Lidia Delrieu, Jeff Vallance, Magali Morelle, Béatrice Fervers, Vincent Pialoux, et al.. Physical activity preferences before and after participation in a 6‐month physical activity intervention among women with metastatic breast cancer. European Journal of Cancer Care, Wiley, 2020, 29 (1), ⟨10.1111/ecc.13169⟩. ⟨hal-02464367⟩
  • Eric Reynes, Sophie Berthouze, Aude-Marie Foucaut, Magali Morelle, Patrick Bachmann, et al.. Effet de l’évolution du profil d’activité quotidienne sur la qualité de vie chez des femmes atteintes de cancers du sein : analyse exploratoire secondaire des données de l’étude PASAPAS. Bulletin du Cancer, John Libbey Eurotext, 2020, 107 (7-8), pp.763-772. ⟨10.1016/j.bulcan.2020.03.014⟩. ⟨halshs-03034365⟩
  • Antoine Liné, Hélène Sudour‐bonnange, Virginie Languillat‐fouquet, Hervé Brisse, Sabine Irtan, et al.. Liver metastasis at diagnosis in children with nephroblastoma enrolled in SIOP2001 protocol: A French multicentric study. Pediatric Blood and Cancer, Wiley, 2020, 67 (6), ⟨10.1002/pbc.28201⟩. ⟨halshs-03036047⟩
  • Lionel Perrier, Aude-Marie Foucaut, Magali Morelle, Marina Touillaud, Anne-Sophie Kempf-Lépine, et al.. Cost-effectiveness of an exercise and nutritional intervention versus usual nutritional care during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial. Supportive Care in Cancer, Springer Verlag (Germany), 2020, 28, pp. 2829-2842. ⟨10.1007/s00520-019-05078-4⟩. ⟨halshs-02378666⟩
  • Lidia Delrieu, Vincent Pialoux, Olivia Pérol, Magali Morelle, Agnès Martin, et al.. Feasibility and health benefits of an individualized physical activity intervention in women with metastatic breast cancer: results of the ABLE single-arm Trial study. JMIR mHealth and uHealth, JMIR Publications, 2020, 8 (1), pp.e12306. ⟨10.2196/12306⟩. ⟨halshs-02389100⟩
  • Line Claude, Magali Morelle, Marc-André Mahé, David Pasquier, Pierre Boisselier, et al.. A comparison of two modalities of stereotactic body radiation therapy for peripheral early-stage non-small cell lung cancer: results of a prospective French study. British Journal of Radiology, British Institute of Radiology, 2020, 93 (1116), pp.20200256. ⟨10.1259/bjr.20200256⟩. ⟨halshs-03003498⟩
  • Nathalie Havet, Alexis Penot, Morgane Plantier, Barbara Charbotel, Magali Morelle, et al.. Inequalities in the control of the occupational exposure in France to carcinogenic, mutagenic and reprotoxic chemicals. European Journal of Public Health, Oxford University Press (OUP): Policy B - Oxford Open Option D, 2019, 29 (1), pp.140-147. ⟨10.1093/eurpub/cky130⟩. ⟨hal-01862797⟩
  • Christophe Pascal, Jean-Baptiste Capgras, Hervé Cazeneuve, Magali Morelle. Les systèmes d’information stratégiques au service des Présidents de Commission médicale d’établissement des centres hospitaliers : une satisfaction élevée pour des usages limités . Journal de Gestion et d’Économie Médicales, Editions ESKA, 2019, pp.510-531. ⟨10.3917/jges.196.0510⟩. ⟨hal-02096525⟩
  • Aude-Marie Foucaut, Magali Morelle, Anne-Sophie Kempf-Lépine, Cédric Baudinet, Renaud Meyrand, et al.. Feasibility of an exercise and nutritional intervention for weight management during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial. Supportive Care in Cancer, Springer Verlag (Germany), 2019, 27 (9), pp. 3449-3461. ⟨10.1007/s00520-019-4658-y⟩. ⟨halshs-02082772⟩
  • Nathalie Havet, Alexis Penot, Morgane Plantier, Magali Morelle, Béatrice Fervers, et al.. Trends in the Control Strategies for Occupational Exposure to Carcinogenic, Mutagenic, and Reprotoxic Chemicals in France (2003-2010). Annals of Work Exposures and Health, Oxford University Press, 2019, 63 (5), pp.488-504. ⟨10.1093/annweh/wxz021⟩. ⟨hal-02476291⟩
  • Nathalie Havet, Alexis Penot, Morgane Plantier, Barbara Charbotel, Magali Morelle, et al.. Do regulations protect workers from occupational exposures to carcinogenic, mutagenic and reprotoxic (CMR) agents in France?. Occupational and Environmental Medicine, BMJ Publishing Group, 2018, 75 (5), pp.389 - 397. ⟨10.1136/oemed-2017-104586⟩. ⟨halshs-01784957⟩
  • Jean-Emmanuel Bibault, Magali Morelle, Marius Huguet, Lionel Perrier, Philippe Giraud. In reply to Jean-François Daisne, Sandra Nuyts, Fréderic Duprez and Benoît Bihin. International Journal of Radiation Oncology - Biology - Physics, Elsevier, 2018, 100 (3), pp. 808-809. ⟨halshs-01651501⟩
  • Jean-Emmanuel Bibault, Magali Morelle, Marius Huguet, Lionel Perrier, Philippe Giraud. In reply to Tallet et al.. International Journal of Radiation Oncology - Biology - Physics, Elsevier, 2018, 100 (2), pp. 529-530. ⟨halshs-01651499⟩
  • Lionel Perrier, S. Baffert, A. Bertaux, J. Bonastre, N. Costa, et al.. Éditorial. Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 2018, 66, pp.S63 - S64. ⟨10.1016/j.respe.2018.02.004⟩. ⟨halshs-01819359⟩
  • Magali Morelle, Morgane Plantier, Benoît Dervaux, Arnaud Pagès, Fanette Deniès, et al.. [Methods for the analysis and treatment of cost data by micro- and gross-costing approaches]. Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 2018, 66, pp.S101 - S118. ⟨10.1016/j.respe.2018.02.003⟩. ⟨halshs-01784310⟩
  • Lionel Perrier, Pauline Rascle, Magali Morelle, Maud Toulmonde, Dominique Ranchere Vince, et al.. The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group. PLoS ONE, Public Library of Science, 2018, 13 (4), ⟨10.1371/journal.pone.0193330⟩. ⟨halshs-01784301⟩
  • Nathalie Havet, Morgane Plantier, Alexis Penot, Barbara Charbotel, Magali Morelle, et al.. Protections des travailleurs vis-à-vis des risques d’exposition aux agents cancérogènes, mutagènes et reprotoxiques (CMR) en France. Environnement, Risques and Santé, John Libbey Eurotext, 2018, 17 (1), pp. 40-47. ⟨halshs-01618724⟩
  • Vanessa Rousseau, Magali Morelle, Céline Arriuberge, Sophie Darnis, Sylvie Chabaud, et al.. Efficacy and tolerance of Lidocaine 5% patches in neuropathic pain and pain related to vaso-occlusive sickle-cell crises in children. Pain Practice, Wiley, 2018, 18 (6), pp. 788-797. ⟨10.1111/papr.12674⟩. ⟨halshs-01670165⟩
  • Marius Huguet, Lionel Perrier, Olivia Bally, David Benayoun, Pierre de Saint Hilaire, et al.. Being Treated In Higher Volume Hospitals Leads To Longer Progression-Free Survival For Epithelial Ovarian Carcinoma Patients in the Rhone-Alpes region of France. BMC Health Services Research, BioMed Central, 2018, 18 (3), 11 p. ⟨10.1186/s12913-017-2802-2⟩. ⟨halshs-01670155⟩
  • Jean-Emmanuel Bibault, Sophie Dussart, Pascal Pommier, Magali Morelle, Marius Huguet, et al.. Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score–Weighted Analysis. International Journal of Radiation Oncology - Biology - Physics, Elsevier, 2017, 99 (4), pp. 929-937. ⟨10.1016/j.ijrobp.2017.06.2456⟩. ⟨halshs-01618896⟩
  • Mathilde Penel-Page, Perrine Marec-Berard, Magali Morelle, Amandine Bertrand, Christèle Riberon, et al.. Management of Febrile Neutropenias in Adolescents and Young Adults: A Cost-Minimization Analysis Between Adult Versus Pediatric Units. Journal of Adolescent and Young Adult Oncology, Mary Ann Liebert, Inc., 2017, 6 (4), pp. 542-550. ⟨10.1089/jayao.2017.0035⟩. ⟨halshs-01618890⟩
  • Lionel Perrier, Magali Morelle, Marius Huguet, Sophie Dussart, Philippe Giraud. In Reply to Escande et al. International Journal of Radiation Oncology - Biology - Physics, Elsevier, 2017, 97 (1), pp. 205-208. ⟨halshs-01421123⟩
  • Nathalie Havet, Alexis Penot, Magali Morelle, Lionel Perrier, Barbara Charbotel, et al.. Varied exposure to carcinogenic, mutagenic, and reprotoxic (CMR) chemicals in occupational settings in France. International Archives of Occupational and Environmental Health, Springer Verlag, 2017, 90 (2), pp. 227-241. ⟨halshs-01446700⟩
  • Nathalie Havet, Alexis Penot, Magali Morelle, Lionel Perrier, Barbara Charbotel, et al.. Trends in occupational disparities for exposure to carcinogenic, mutagenic and reprotoxic chemicals in France 2003–10 . European Journal of Public Health, Oxford University Press (OUP): Policy B - Oxford Open Option D, 2017, 27 (3), pp.425-432. ⟨10.1093/eurpub/ckx036⟩. ⟨halshs-01524444⟩
  • Lionel Perrier, Magali Morelle, Pascal Pommier, Pierre Boisselier, Bernard Coche-Dequeant, et al.. A cost analysis of complex radiotherapy for patients with head and neck cancer. International Journal of Radiation Oncology - Biology - Physics, Elsevier, 2016, 95 (2), pp. 654-662 ⟨10.1016/j.ijrobp.2016.02.013⟩. ⟨halshs-01300834⟩
  • J-E Bibault, Magali Morelle, Lionel Perrier, Pascal Pommier, Pierre Boisselier, et al.. Toxicity and efficacy of cetuximab associated with several modalitiesof IMRT for locally advanced head and neck cancer. Cancer Radiothérapie, Elsevier Masson, 2016, 20 (5), pp. 357-361. ⟨10.1016/j.canrad.2016.05.009⟩. ⟨halshs-01366224⟩
  • Line Claude, Magali Morelle, Sandrine Mancini, Anita Duncan, Henri Sebban, et al.. Radiothérapie des enfants de moins de cinq ans : peut-on limiter les anesthésies itératives par les rituels et l'hypnose . Bulletin du Cancer, John Libbey Eurotext, 2016, 103 (11), pp. 921-927. ⟨halshs-01447593⟩
  • Lionel Perrier, Magali Morelle, Sophie Dussart, Philippe Giraud. In Reply to Fodor and Di Muzio. International Journal of Radiation Oncology - Biology - Physics, Elsevier, 2016, 96 (5), pp. 1124-1126. ⟨halshs-01421125⟩
  • Christine Durif-Bruckert, Pauline Roux, Magali Morelle, H. Mignotte, C. Faure, et al.. Shared decision making in medical encounters regarding breast cancer treatment: the contribution of methodological triangulation. European Journal of Cancer Care, Wiley, 2015, 24 (4), pp. 461-472. ⟨10.1111/ecc.12214⟩. ⟨halshs-01206593⟩
  • Nathalie Havet, Magali Morelle, Alexis Penot, Raphaël Remonnay. Understanding the patients’ preferences for home blood transfusion : a WTA-WTP Analysis. Journal de Gestion et d’Économie Médicales, Editions ESKA, 2015, 33 (1), pp. 45-59. ⟨halshs-01157693⟩
  • Aude-Marie Foucaut, Sophie Berthouze, Marina Touillaud, Magali Morelle, Valérie Bourne-Branchu, et al.. Deterioration of Physical Activity Level and Metabolic Risk Factors After Early-Stage Breast Cancer Diagnosis. Cancer Nursing, Lippincott, Williams & Wilkins, 2014, 38 (4), pp.E1-E9. ⟨10.1097/NCC.0000000000000187⟩. ⟨hal-02128290⟩
  • Nathalie Havet, Alexis Penot, Magali Morelle, Lionel Perrier, Béatrice Fervers. Inégalités de l'exposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France. Environnement, Risques and Santé, John Libbey Eurotext, 2014, 13 (4), pp. 336-341. ⟨halshs-01080555⟩
  • Magali Morelle, Lionel Perrier, Pascal Pommier, Frédéric Gomez, F. Millet-Lagarde, et al.. Curiethérapie : valorisation et aspects médico-économiques. Cancer Radiothérapie, Elsevier Masson, 2013, 17 (2), pp. 178-181. ⟨halshs-00862738⟩
  • Lionel Perrier, Magali Morelle, Pascal Pommier. Cost of prostate image-guided radiation therapy: Results of a randomized trial. Radiotherapy and Oncology, Elsevier, 2013, 106 (1), pp. 50-58. ⟨halshs-00799507⟩
  • Lionel Perrier, Magali Morelle, Pascal Pommier, Jean-Léon Lagrange, Agnès Laplanche, et al.. Cost of prostate image-guided radiation therapy: results of a randomized trial.. Radiotherapy and Oncology, Elsevier, 2013, 106 (1), pp.50-8. ⟨10.1016/j.radonc.2012.11.011⟩. ⟨hal-00880252⟩
  • Magali Morelle, Lionel Perrier, Pascal Pommier, Renaud de Crevoisier, Agnès Laplanche, et al.. Evaluation économique prospective de la radiothérapie guidée par l'image des cancers de la prostate dans le cadre du programme national de Soutien aux Thérapeutiques Innovantes et Coûteuses. Cancer Radiothérapie, Elsevier Masson, 2012, 16 (5-6), pp. 444-451. ⟨halshs-00752616⟩
  • Marie-Odile Carrère, Nathalie Havet, Magali Morelle, Raphaël Remonnay. Cancer Patients' Willingness to Pay for Blood Transfusion at Home: Results from a contingent valuation study in a French cancer network. European Journal of Health Economics, Springer Verlag, 2012, 13 (3), pp. 289-300. ⟨halshs-00642497⟩
  • Marie-Odile Carrère, Nathalie Havet, Magali Morelle, Raphaël Remonnay. Economic treatment of few protest responses in willingness-to-pay studies: An application in health care. Recherches Economiques de Louvain - Louvain economic review, De Boeck Université, 2012, 78 (2), pp. 53-74. ⟨halshs-00681345⟩
  • Marie-Odile Carrère, Magali Morelle. Respiratory gating techniques for optimization of lung cancer radiotherapy. Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2011, 6 (12), pp. 2058-2068. ⟨halshs-00667282⟩
  • Marie-Odile Carrère, Nathalie Havet, Magali Morelle, Raphaël Remonnay. Valuing the Benefit for Cancer Patients of Receiving Blood Transfusions at Home. Journal of Benefit-Cost Analysis, Cambridge University Press, 2011, 2 (3), pp.Article 4. ⟨10.2202/2152-2812.1017⟩. ⟨halshs-00642500⟩
  • Nathalie Havet, Magali Morelle, Lionel Perrier, Bertrand Favier, Frédéric Gomez, et al.. Impact of chemotherapy prescriptions and costs on survival in advanced or metastatic NSCLC: a single-institution study using an instrumental variables approach. Journal d'Economie Médicale, Masson, 2010, 28 (8), pp. 295-310. ⟨halshs-00667277⟩
  • Marie-Odile Carrère, Magali Morelle, Pascal Pommier, Raphaël Remonnay. Evaluation économique de la curiethérapie pulsée gynécologique (PDR) avec optimisation de la dose pour les cancers du col utérin. Cancer Radiothérapie, Elsevier Masson, 2010, 14 (3), pp. 161-168. ⟨halshs-00451555⟩
  • Christophe Bergeron, Pierre Biron, Jean-Yves Blay, Nicola Cautela, Dominic Cellier, et al.. Costs and compliance with clinical practice guidelines: A pilot study for initial sarcoma treatment. Journal d'Economie Médicale, Masson, 2009, 27 (6), pp. 307-327. ⟨halshs-00954975⟩
  • Raphaël Remonnay, Magali Morelle, Francesco Giammarile, Pascal Pommier, Marie-Odile Carrère. L'apport de la tomographie par émission de positons au FDG pour la radiothérapie : résultats de l'évaluation économique du Stic « TEP et radiothérapie ». Cancer Radiothérapie, Elsevier Masson, 2009, 13 (4), pp. 313-317. ⟨halshs-00451570⟩
  • Magali Morelle, Raphaël Remonnay, Philippe Giraud, Marie-Odile Carrère. Analyzing multiple learning effects in health care using multilevel modelling - Application to radiotherapy at an early stage of innovation. International Journal of Technology Assessment in Health Care, Cambridge University Press (CUP), 2009, 25 (2), pp. 232-239. ⟨halshs-00451527⟩
  • Magali Morelle, Raphaël Remonnay, Philippe Giraud, Marie-Odile Carrère. Évaluation du coût de la radiothérapie asservie à la respiration dans le cadre d'un projet Stic. Cancer Radiothérapie, Elsevier Masson, 2009, 13 (4), pp. 281-290. ⟨halshs-00451534⟩
  • Nora Moumjid, Cathy Charles, Magali Morelle, Amiram Gafni, Alain Brémond, et al.. The statutory duty of physicians to inform patients versus unmet patient's information needs: the case of breast cancer in France. Health Policy, Elsevier, 2009, 91 (2), pp. 162-173. ⟨halshs-00451610⟩
  • Marie-Odile Carrère, Yves Devaux, Nathalie Havet, Magali Morelle, Raphaël Remonnay, et al.. Administration des transfusions sanguines à l'hôpital ou à domicile ? Le choix des patients atteints de cancer. Bulletin du Cancer, John Libbey Eurotext, 2008, 95 (11), pp. 1-7. ⟨halshs-00353328⟩
  • Raphaël Remonnay, Magali Morelle, Pascal Pommier, Francesco Giammarile, Marie-Odile Carrère. Assessing short-term effects and costs at an early stage of innovation: The use of positron emission tomography on radiotherapy treatment decision making. International Journal of Technology Assessment in Health Care, Cambridge University Press (CUP), 2008, 24 (2), pp. 212-220. ⟨halshs-00333752⟩
  • Magali Morelle, Lionel Perrier, Hervé Ghesquières, Catherine Sebban, Irène Philip, et al.. The impact of CD34+ cell dose on the cost of HDT with PBSC transplantation in lymphomia. Journal dÉconomie Médicale, 2007, 25 (1), pp.3-15. ⟨halshs-00159806⟩
  • Magali Morelle. Effects of residential distance to hospitals with neonatal surgery care on prenatal management and outcome of pregnancies with severe fetal malformations. Ultrasound in Obstetrics and Gynecology = Ultrasound in Obstetrics & Gynecology, Wiley-Blackwell, 2007, pp.271-275. ⟨halshs-00164898⟩
  • Marie-Odile Carrère, Magali Morelle. Cost-effectiveness analysis of strategies for HER2 testing of breast cancer patients in France. International Journal of Technology Assessment in Health Care, Cambridge University Press (CUP), 2006, 22 (3), pp. 396-401. ⟨halshs-00266848⟩
  • Hans-Martin Späth, Marie Charavel, Magali Morelle, Marie-Odile Carrère. Formulary decision-making in public hospitals and private clinics in France: the role of pharmacoeconomic information. Journal d'Economie Médicale, Masson, 2005, 7-8, pp. 347-354. ⟨halshs-00365954⟩
  • Raphaël Remonnay, Marie-Odile Carrère, Magali Morelle, Yves Devaux, Gisèle Chvetzoff. Cancer treatment at home or in the hospital: what are the costs for French public health insurance? Findings of a comprehensive cancer centre. Health Policy, Elsevier, 2005, 72 (2), pp.141-148. ⟨halshs-00156716⟩
  • Lionel Perrier, Karima Nessah, Magali Morelle, Hervé Mignotte, Marie-Odile Carrère, et al.. Cost comparison of two surgical strategies in the treatment of breast cancer: Sentinel lymph node biopsy versus axillary lymph node dissection. International Journal of Technology Assessment in Health Care, Cambridge University Press (CUP), 2004, 20 (4), pp. 449-454. ⟨halshs-00335472⟩
  • Hans-Martin Späth, Marie Charavel, Magali Morelle, Marie-Odile Carrère. A qualitative approach to the use of economic data in the selection of medecines for hospital formularies: a French survey. Pharmacy World and Science, Springer Verlag, 2003, 25 (6), pp. 269-275. ⟨halshs-00335137⟩
  • Nora Moumjid, Magali Morelle, Marie-Odile Carrère, Thomas Bachelot, Hervé Mignotte, et al.. Elaborating patient information with patients themselves: lessons from a cancer treatment focus group. Health Expectations, Wiley, 2003, 6 (2), pp. 128-139. ⟨halshs-00335479⟩
  • Lionel Perrier, Catherine Sebban, Irène Philip, Baudouin Standaert, Magali Morelle, et al.. Vers une nécessaire harmonisation des évaluations de coûts en santé. L'exemple des intensifications thérapeutiques avec autogreffes de cellules souches du sang périphérique en France. Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 2002, 50 (4), pp. 393-403. ⟨halshs-00335619⟩
  • Magali Morelle, Nora Moumjid, Alain Brémond, Marie Charavel, Marie-Odile Carrère. Comment évaluer la qualité du transfert de l'information du médecin au patient ? Le choix des tests psychométriques d'un tableau de décision dans un Centre Régional de Lutte contre le Cancer. Epidemiology and Public Health / Revue d'Epidémiologie et de Santé Publique, Elsevier Masson, 2001, 49, pp. 299-313. ⟨halshs-00335128⟩

Conference papers14 documents

  • Lionel Perrier, Denis Koala, Marius Huguet, Magali Morelle, Vincent Augusto, et al.. Optimisation du parcours de soins dans la prise en charge initiale des cancers épithéliaux ovariens en France. 10ème Journée Nationale des Innovations Hospitalières, Jun 2019, Paris, France. ⟨halshs-02197090⟩
  • Aude-Marie Foucaut, Marina Touillaud, A. S. Kempf-Lépine, Magali Morelle, Dominik Heinz, et al.. A cost-effectiveness analysis of a 6-month physical activity program versus usual dietary care during adjuvant chemotherapy in breast cancer: An economic evaluation of the PASAPAS trial. . 21th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Washington, May 2016, Washington, United States. ⟨halshs-01421080⟩
  • Nathalie Havet, Alexis Penot, Magali Morelle, Béatrice Fervers, Barbara Charbotel, et al.. Inégalités d’exposition aux agents cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France : les enseignements de l'enquête SUMER. DARES, "Risques du travail", Oct 2014, Paris, France. ⟨halshs-01087916⟩
  • Nathalie Havet, Magali Morelle, Alexis Penot, Béatrice Fervers, Lionel Perrier. Les fortes expositions aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) sont-elles l'apanage des emplois précaires et peu qualifiés ?. Journée d'Economie et de Gestion Médicale, Paris, 28 janvier 2014, Jan 2014, Paris, France. ⟨halshs-00954964⟩
  • Alexis Penot, Magali Morelle, Béatrice Fervers, Lionel Perrier. Inégalités de l’exposition aux produits chimiques cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : les enseignements de l’enquête SUMER. Risques au travail : autour de SUMER 2010, DARES, Oct 2014, Paris, France. ⟨halshs-01076915⟩
  • Nathalie Havet, Magali Morelle, Alexis Penot, Béatrice Fervers, Lionel Perrier. Inégalités de l'exposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : SUMER 2010. 4ème Congrès Cancer et Environnement de la Société Française Santé et Environnement, Lyon, 28-29 novembre 2013, Nov 2013, Lyon, France. ⟨halshs-00954966⟩
  • Lionel Perrier, Magali Morelle, Pascal Pommier, Jean-Léon Lagrange, Agnès Laplanche, et al.. A cost-analysis of image-guided radiation therapy (IGRT) in prostate cancer: results from a phase III clinical trial. ISPOR, 15th Annual European Congress 3-7 November 2012, Berlin, Germany, Nov 2012, Berlin, Allemagne. page A416. ⟨halshs-00752908⟩
  • Lionel Perrier, Dominique Ranchère-Vince, P. Terrier, A. Neuville, Anne-Valérie Decouvelaere, et al.. Discordant diagnoses in sarcoma, GIST and desmoide tumour in France: results from the network RREPS. ISPOR, 15th Annual European Congress 3-7 November 2012, Berlin, Germany, Nov 2012, Berlin, Germany. page A285. ⟨halshs-00752854⟩
  • Pascal Pommier, Magali Morelle, Lionel Perrier, Renaud de Crevoisier, A. Laplanche, et al.. Évaluation économique prospective de la radiothérapie guidée par l'image des cancers de la prostate dans le cadre du programme national de soutien aux thérapeutiques innovantes et coûteuses. [Prospective economic evaluation of image-guided radiation therapy for prostate cancer in the framework of the national programme for innovative and costly therapies assessment.]. 23e Congrès national de la Société française de radiothérapie oncologique (SFRO), Sep 2012, Paris, France. pp.444-451, ⟨10.1016/j.canrad.2012.07.178⟩. ⟨hal-00905545⟩
  • Magali Morelle, Nora Moumjid, Valérie Buthion, Jennifer Margier. Eliciting patients' preferences for local medical management versus centralized technical support using a computerized decision aid based on contingent valuation survey: an innovative method tested in cancer. 6th International Shared Decision Making Conference, Maastricht, 19-22 June 2011, Jun 2011, Maastricht, Netherlands. ⟨halshs-00672125⟩
  • Marie-Odile Carrère, Yves Devaux, Magali Morelle, Raphaël Remonnay. An assessment of the ability of contingent valuation (CV) to elicit patients' preferences for the organization of home care: The case of blood transfusion (BT). Journées de l'AFSE et de l'économie expérimentale ; Lyon, 23 au 25 mai 2007, 2007, Lyon, France. ⟨halshs-00266784⟩
  • Marie-Odile Carrère, Magali Morelle, Raphaël Remonnay. Economic assessment of innovation in radiotherapy: impact of FDG PET scan on treatment decision and target volume in lung cancer and Hodgkin's disease. 6th European Conference on Health Economics, Budapest, July 6-13, 2006, 2006, Budapest, Hungary. ⟨halshs-00266776⟩
  • Marie-Odile Carrère, Magali Morelle. Cost-effectiveness analysis of strategies for HER2/neu testing of breast cancer patients in France. Second British-French Meeting on Health Economics London, 4-6 janvier 2006, 2006, London, United Kingdom. ⟨halshs-00266191⟩
  • Marie-Odile Carrère, Yves Devaux, Magali Morelle, Raphaël Remonnay. A cost-benefit analysis of outpatient blood transfusion in patients with cancer. 5th world International Health Economics Association (IHEA) conference, Barcelona, July2005, 2005, Barcelona, Spain. ⟨halshs-00266148⟩

Book sections1 document

  • Alain Brémond, Marie-Odile Carrère, Magali Morelle, Nora Moumjid. Quels sont les besoins d'information des patients ? Le cas du cancer du sein dans un réseau. Coordonné par Patrick Castel et Marie-Odile Carrère. Soins en réseau. Pratiques, acteurs et régulation en cancérologie, Editions John Libbey Eurotext, pp. 47-59, 2007. ⟨halshs-00266865⟩

Other publications3 documents

  • Lionel Perrier, Magali Morelle, Nathalie Havet, Anthony Montella, Bertrand Favier, et al.. The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer. 2009. ⟨halshs-00371825⟩
  • Marie-Odile Carrère, Nathalie Havet, Magali Morelle, Raphaël Remonnay. Analyzing the determinants of willingness-to-pay values for testing the validity of the contingent valuation method. Application to home care compared to hospital care. 2008. ⟨halshs-00303725⟩
  • Lionel Perrier, Nicola Cautela, Magali Morelle, Nathalie Havet, Françoise Ducimetière, et al.. Short-Term cost impact of compliance with clinical practice guidelines for initial sarcoma treatment. 2008. ⟨halshs-00322614⟩

Preprints, Working Papers, ...3 documents

  • Marius Huguet, Lionel Perrier, Olivia Bally, Xavier Joutard, Nathalie Havet, et al.. Counterfactual approach with survival or time to event outcomes: An application to an exhaustive cohort of Epithelial Ovarian Carcinoma in the Rhône-Alps region of France. 2016. ⟨halshs-01333480⟩
  • Nathalie Havet, Alexis Penot, Magali Morelle, Lionel Perrier, Béatrice Fervers. Inégalités d'exposition aux agents cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France. 2014. ⟨halshs-01098761⟩
  • Nathalie Havet, Magali Morelle, Alexis Penot, Raphaël Remonnay. The information content of the WTP-WTA gap : An empirical analysis among severely ill patients. 2012. ⟨halshs-00697762⟩

Reports1 document

  • Nathalie Havet, Alexis Penot, Magali Morelle, Lionel Perrier, Béatrice Fervers. Inégalités de l'exposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : les enseignements de l'enquête SUMER: Rapport final de recherche pour la DARES, Ministère de la santé et de la solidarité. [Rapport de recherche] Direction de l'animation de la recherche, des études et des statistiques (DARES). 2014. ⟨halshs-01080585⟩